Press Release Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 18 hours ago
Press Release Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 Aug 4
Press Release Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome Aug 3